|
RIPK1 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 6.443200E-03 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.112300E-02 |
| Normal-vs-Stage2 |
3.365400E-01 |
| Normal-vs-Stage3 |
3.355900E-02 |
| Normal-vs-Stage4 |
3.818000E-03 |
| Stage1-vs-Stage2 |
8.421400E-01 |
| Stage1-vs-Stage3 |
4.977400E-01 |
| Stage1-vs-Stage4 |
2.700800E-01 |
| Stage2-vs-Stage3 |
5.248800E-01 |
| Stage2-vs-Stage4 |
3.011400E-01 |
| Stage3-vs-Stage4 |
5.226000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.976800E-03 |
| Normal-vs-AfricanAmerican |
1.661400E-01 |
| Normal-vs-Asian |
1.458180E-01 |
| Caucasian-vs-AfricanAmerican |
3.460800E-01 |
| Caucasian-vs-Asian |
9.873600E-01 |
| AfricanAmerican-vs-Asian |
7.235000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
7.161800E-03 |
| Normal-vs-Female |
5.314400E-02 |
| Male-vs-Female |
8.627600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
7.364200E-03 |
| Normal-vs-Extreme_Weight |
5.915400E-03 |
| Normal-vs-Obese |
1.517600E-01 |
| Normal-vs-Extreme_Obese |
1.880340E-02 |
| Normal_Weight-vs-Extreme_Weight |
8.041600E-01 |
| Normal_Weight-vs-Obese |
2.034800E-01 |
| Normal_Weight-vs-Extreme_Obese |
8.532000E-01 |
| Extreme_Weight-vs-Obese |
2.568200E-01 |
| Extreme_Weight-vs-Extreme_Obese |
7.555200E-01 |
| Obese-vs-Extreme_Obese |
3.497400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.386370E-01 |
| Normal-vs-Age(41-60Yrs) |
3.652200E-01 |
| Normal-vs-Age(61-80Yrs) |
5.833400E-04 |
| Normal-vs-Age(81-100Yrs) |
3.089800E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.345200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.349000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.463390E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.819300E-03 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.878300E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.782400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
2.670600E-01 |
| Normal-VS-Type2 PRCC |
2.766000E-04 |
| Normal-VS-KIRP CIMP |
4.41789999999775E-05 |
| Normal-VS-Unclassified PRCC |
8.817800E-02 |
| Type1 PRCC-VS-Type2 PRCC |
1.281320E-03 |
| Type1 PRCC-VS-KIRP CIMP |
9.017900E-04 |
| Type1 PRCC-VS-Unclassified PRCC |
2.321400E-01 |
| Type2 PRCC-VS-KIRP CIMP |
1.577220E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
2.752400E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
3.435900E-02 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.616800E-04 |
| Normal-vs-N1 |
5.242000E-02 |
| Normal-vs-N2 |
1.65489999999213E-05 |
| N0-vs-N1 |
3.342800E-01 |
| N0-vs-N2 |
5.264300E-02 |
| N1-vs-N2 |
1.868320E-02 |
|
|
